Gilead Sciences to Present at Upcoming Investor Engagements

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:

• Jefferies London Healthcare Conference on Wednesday, November 20 at 9:30 AM Greenwich Mean Time
• Piper Sandler Annual Healthcare Conference on Tuesday, December 3 at 11:00 AM Eastern Time
• Annual Evercore ISI HealthCONx Conference on Wednesday, December 4 at 11:40 AM Eastern Time

The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241108042891/en/

Jacquie Ross, CFA – Investors
[email protected]

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings
• BNB Remains a Market Giant as IceBull’s $5K Stage 1 Start Fuels the Next 1000x Crypto Search
• ATTACK SHARK Unveils R86 HE Carbon Fiber Magnetic Switch Gaming Keyboard, Redefining the 75% Competitive Keyboard Experience